| 000 | 01638 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517142730.0 | ||
| 264 | 0 | _c20180306 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1537-162X | ||
| 024 | 7 |
_a10.1097/WNF.0000000000000211 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Frutos-Lezaun, Marta | |
| 245 | 0 | 0 |
_aBilateral Retrobulbar Optic Neuropathy Associated With Golimumab. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c |
||
| 300 |
_a149-151 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelin Sheath _xdrug effects |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOptic Nerve _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOptic Neuritis _xchemically induced |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVision, Low _xetiology |
| 700 | 1 | _aBidaguren, Aritz | |
| 700 | 1 | _ade la Riva, Patricia | |
| 700 | 1 | _aMeneses, Carlos F | |
| 700 | 1 | _aOlascoaga, Javier | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 40 _gno. 3 _gp. 149-151 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNF.0000000000000211 _zAvailable from publisher's website |
| 999 |
_c26952963 _d26952963 |
||